| scholarly article | Q13442814 |
| P2093 | author name string | A D Michel | |
| E Fonfria | |||
| P2860 | cites work | Human TREK2, a 2P domain mechano-sensitive K+ channel with multiple regulations by polyunsaturated fatty acids, lysophospholipids, and Gs, Gi, and Gq protein-coupled receptors | Q22254402 |
| Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor | Q24306745 | ||
| Proteomic and functional evidence for a P2X7 receptor signalling complex | Q24535912 | ||
| Regulation of sodium channel function by bilayer elasticity: the importance of hydrophobic coupling. Effects of Micelle-forming amphiphiles and cholesterol | Q24651929 | ||
| Molecular physiology of P2X receptors | Q28203477 | ||
| Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction | Q28205106 | ||
| Blockade of human P2X7 receptor function with a monoclonal antibody | Q77531722 | ||
| Retraction | Q28302699 | ||
| The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7) | Q28568856 | ||
| RETRACTED: Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. | Q34085160 | ||
| Sphingosylphosphocholine, a signaling molecule which accumulates in Niemann-Pick disease type A, stimulates DNA-binding activity of the transcription activator protein AP-1 | Q34162004 | ||
| Receptors for protons or lipid messengers or both? | Q34583409 | ||
| Sphingosylphosphorylcholine-biological functions and mechanisms of action | Q34691524 | ||
| ATP, a partial agonist for the P2Z receptor of human lymphocytes | Q35026800 | ||
| Membrane targeted anticancer drugs: potent inducers of apoptosis and putative radiosensitisers | Q35181155 | ||
| Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis | Q36348728 | ||
| Modulation of P2X7 receptor functions by polymyxin B: crucial role of the hydrophobic tail of the antibiotic molecule. | Q36357782 | ||
| P2 receptors and cancer | Q36418844 | ||
| Lysophospholipids modulate channel function by altering the mechanical properties of lipid bilayers | Q36435393 | ||
| Miltefosine: oral treatment of leishmaniasis | Q36441483 | ||
| Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium | Q37031335 | ||
| Lysophosphatidylcholine potentiates Ca2+ influx, pore formation and p44/42 MAP kinase phosphorylation mediated by P2X7 receptor activation in mouse microglial cells | Q40145211 | ||
| Lysophosphatidylcholine stimulates IL-1beta release from microglia via a P2X7 receptor-independent mechanism | Q40201601 | ||
| GABA(A) receptor function is regulated by lipid bilayer elasticity | Q40216662 | ||
| Decavanadate, a P2X receptor antagonist, and its use to study ligand interactions with P2X7 receptors | Q40314793 | ||
| Sensing of lysophospholipids by TRPC5 calcium channel | Q40337792 | ||
| Pharmacological and biophysical properties of the human P2X5 receptor | Q40645853 | ||
| Rapid secretion of interleukin-1beta by microvesicle shedding | Q40765816 | ||
| Apparent species differences in the kinetic properties of P2X(7) receptors | Q40883984 | ||
| Lysophosphatidylcholine induces arachidonic acid release and calcium overload in cardiac myoblastic H9c2 cells. | Q40925478 | ||
| Pore dilation of neuronal P2X receptor channels | Q40960421 | ||
| Properties of the pore-forming P2X7 purinoceptor in mouse NTW8 microglial cells | Q41097625 | ||
| Direct labelling of the human P2X7 receptor and identification of positive and negative cooperativity of binding | Q41556777 | ||
| Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds. | Q41646184 | ||
| Direct activation of Ca2+ channels by palmitoyl carnitine, a putative endogenous ligand | Q41788033 | ||
| Effects of lysophosphatidylcholine on resting potassium conductance of isolated guinea pig ventricular cells | Q41922246 | ||
| Species- and agonist-dependent differences in the deactivation-kinetics of P2X7 receptors | Q43646177 | ||
| ADP and AMP induce interleukin-1beta release from microglial cells through activation of ATP-primed P2X7 receptor channels. | Q43954485 | ||
| An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma | Q44149378 | ||
| Tyrosine phosphorylation of HSP90 within the P2X7 receptor complex negatively regulates P2X7 receptors | Q44517513 | ||
| Alteration of the membrane lipid environment by L-palmitoylcarnitine modulates K(ATP) channels in guinea-pig ventricular myocytes | Q46264995 | ||
| Exogenous lysophosphatidylcholine increases non-selective cation current in guinea-pig ventricular myocytes | Q46461650 | ||
| Identification of a lysophosphatidylserine receptor on mast cells. | Q46929883 | ||
| Potentiation of native and recombinant P2X7-mediated calcium signaling by arachidonic acid in cultured cortical astrocytes and human embryonic kidney 293 cells | Q46970853 | ||
| Lysophosphatidylcholine induces the production of IL-1beta by human monocytes | Q47987190 | ||
| Opposite modulation of NMDA receptors by lysophospholipids and arachidonic acid: common features with mechanosensitivity | Q48355564 | ||
| Activation by P2X7 agonists of two phospholipases A2 (PLA2) in ductal cells of rat submandibular gland. Coupling of the calcium-independent PLA2 with kallikrein secretion. | Q50521928 | ||
| Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects | Q57791049 | ||
| Ischemic poison lysophosphatidylcholine modifies heart sodium channels gating inducing long-lasting bursts of openings | Q69364354 | ||
| Pathophysiological concentrations of lysophosphatides and the slow response | Q70443985 | ||
| Increased lysophosphatidylcholine content in lesional psoriatic skin | Q70861418 | ||
| Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium | Q71394505 | ||
| Effect of sphingosylphosphorylcholine on the single channel gating properties of the cardiac ryanodine receptor | Q73169534 | ||
| Lysophosphatidylcholine triggers intracellular calcium release and activation of non-selective cation channels in renal arterial smooth muscle cells | Q73457826 | ||
| ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors | Q73767661 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipid | Q11367 |
| P304 | page(s) | 523-537 | |
| P577 | publication date | 2007-08-13 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Agonist potency at P2X7 receptors is modulated by structurally diverse lipids | |
| P478 | volume | 152 |
| Q93115123 | ATP release drives heightened immune responses associated with hypertension |
| Q38936183 | Activated microglia in ischemic stroke penumbra upregulate MCP-1 and CCR2 expression in response to lysophosphatidylcholine derived from adjacent neurons and astrocytes |
| Q35122793 | Activation and regulation of purinergic P2X receptor channels |
| Q36825825 | Allosteric modulation of ATP-gated P2X receptor channels |
| Q33948890 | CD39 is a negative regulator of P2X7-mediated inflammatory cell death in mast cells |
| Q33801926 | Clemastine potentiates the human P2X7 receptor by sensitizing it to lower ATP concentrations. |
| Q33509374 | Cloning and pharmacological characterization of the dog P2X7 receptor |
| Q39708017 | Diadenosine homodinucleotide products of ADP-ribosyl cyclases behave as modulators of the purinergic receptor P2X7. |
| Q37401620 | Differential regulation of P2X7 receptor activation by extracellular nicotinamide adenine dinucleotide and ecto-ADP-ribosyltransferases in murine macrophages and T cells. |
| Q39956832 | Identification of regions of the P2X(7) receptor that contribute to human and rat species differences in antagonist effects |
| Q34680399 | Lipin-2 regulates NLRP3 inflammasome by affecting P2X7 receptor activation. |
| Q35214735 | Lipopolysaccharide inhibits the channel activity of the P2X7 receptor |
| Q42363539 | Mycobacterium tuberculosis synergizes with ATP to induce release of microvesicles and exosomes containing major histocompatibility complex class II molecules capable of antigen presentation |
| Q40037039 | Negative and positive allosteric modulators of the P2X(7) receptor |
| Q34509716 | Plasma membrane cholesterol as a regulator of human and rodent P2X7 receptor activation and sensitization |
| Q36379060 | Sphingosine regulates the NLRP3-inflammasome and IL-1β release from macrophages. |
| Q40235535 | The ATP Receptors P2X7 and P2X4 Modulate High Glucose and Palmitate-Induced Inflammatory Responses in Endothelial Cells |
| Q37142680 | The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner. |
Search more.